cornellleukemia.com
Weill Cornell Medical College and Cellectis Announce Research Alliance Advancing Drug Discovery and the Translation of Novel Immunotherapies in Leukemia
Collaboration Will Focus on Improving Patient Outcomes in AML Using Targeted Cellular Therapy Developed by Cellectis June 02, 2015 05:00 PM Eastern Daylight Time NEW YORK–(BUSINESS WIRE)&#821…